| A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorub | Phase II | rekrutiert |
| A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease | Phase III | rekrutiert |
| A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world Sett | — | rekrutiert |
| A Long-term Extension Study of PCI-32765 (Ibrutinib) | Phase III | rekrutiert |
| A Multicenter Multinational Observational Study of Children With Hypochondroplasia | — | rekrutiert |
| A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Scle | — | rekrutiert |
| A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor f | — | rekrutiert |
| A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Diseas | Phase II | rekrutiert |
| A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Even | Phase III | rekrutiert |
| A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo i | Phase III | rekrutiert |
| A Phase-3-trial of Acalabrutinib, Obinutuzumab & Venetoclax Compared to Obinutuzumab and Venetoc | Phase III | rekrutiert |
| A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propi | Phase III | rekrutiert |
| A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Mode | Phase II | rekrutiert |
| A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelod | Phase III | rekrutiert |
| A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tra | Phase III | rekrutiert |
| A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoP | — | rekrutiert |
| A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months | Phase II | rekrutiert |
| A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With | Phase III | rekrutiert |
| A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult an | Phase III | rekrutiert |
| A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Parti | Phase III | rekrutiert |
| A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients W | Phase II | rekrutiert |
| A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive | Phase III | rekrutiert |
| A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in | Phase II | rekrutiert |
| A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Level | — | rekrutiert |
| A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 i | Phase I | rekrutiert |
| AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Exc | Phase III | rekrutiert |
| ARTICE® Real Data Collection & Observational Trial, Phase 4 Study | — | rekrutiert |
| An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psor | — | rekrutiert |
| An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly | — | rekrutiert |
| An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-ter | Phase III | rekrutiert |
| An Open-label Study of AZD0120 in Adults With Multiple Sclerosis | Phase I | rekrutiert |
| An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in | Phase III | rekrutiert |
| Anatomical Resection of Liver MetAstases iN patIents With RAS-mutated Colorectal Cancer | ohne Phasenangabe | rekrutiert |
| Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG | Phase III | rekrutiert |
| Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipopr | Phase III | rekrutiert |
| Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment | — | rekrutiert |
| CORCYM Mitral, Aortic aNd Tricuspid Post-maRket Study in a reAl-world Setting | — | rekrutiert |
| Colorectal Resections in Patients With Retroperitoneal Sarcoma | — | rekrutiert |
| Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracra | ohne Phasenangabe | rekrutiert |
| Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI | ohne Phasenangabe | rekrutiert |
| Cyclosporine In Takotsubo Syndrome | Phase II | rekrutiert |
| DERIVO® 2heal® Study: Clinical Safety and Efficacy of the DERIVO® 2heal® Embolisation Device | — | rekrutiert |
| EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagl | Phase III | rekrutiert |
| EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in Peop | Phase III | rekrutiert |
| EURO-STIM Registry | — | rekrutiert |
| Efficacy and Safety of Oral Controlled-Ileocolonic-Release Nicotinamide (CICR-NAM) in Patients W | Phase II / Phase III | rekrutiert |
| Efficacy of Add-on Plasma Exchange As an Adjunctive Strategy Against Septic Shock | ohne Phasenangabe | rekrutiert |
| European Registry on the Management of Helicobacter Pylori Infection | — | rekrutiert |
| Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With | Phase III | rekrutiert |
| GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, T | — | rekrutiert |
| German Dementia Registry | — | rekrutiert |
| German MPN-Registry for BCR-ABL 1-Negative Myeloid Neoplasms (Study Group Ulm) | — | rekrutiert |
| Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children a | — | rekrutiert |
| HIPEC + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJ (PREVENT) | Phase III | rekrutiert |
| IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors | Phase I / Phase II | rekrutiert |
| ITP Registry and Accompanying Biospecimen Collection | — | rekrutiert |
| International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lym | Phase III | rekrutiert |
| International HIT-MED Registry (I-HIT-MED) | — | rekrutiert |
| JuggerStitch Post Market Clinical Follow-up Study | ohne Phasenangabe | rekrutiert |
| KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generali | Phase II / Phase III | rekrutiert |
| LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Cal | Phase III | rekrutiert |
| LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MAS | Phase III | rekrutiert |
| Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells | Phase II / Phase III | rekrutiert |
| Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia | Phase III | rekrutiert |
| MB-CART19.1 in Refractory SLE | Phase I / Phase II | rekrutiert |
| Managing Congestion in Heart Failure: A Mechanistic Study in Patients With HFpEF | ohne Phasenangabe | rekrutiert |
| NIS to Examine the Effectiveness and Safety of Durvalumab and Olaparib in Patients With Endometr | — | rekrutiert |
| Nationwide Uniform Scientific Evaluation of Flexible and Integrated Treatment Projects From 2022 | — | rekrutiert |
| Next-Generation-Sequencing Approach to Neutropenic Sepsis | — | rekrutiert |
| Nivolumab in Children and Adults With Nasopharyngeal Carcinoma | Phase II | rekrutiert |
| Observational Study Protocol: LIVER-R | — | rekrutiert |
| PROCARE - PROstate Cancer Real World Evidence Registry | — | rekrutiert |
| PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and | — | rekrutiert |
| Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With New | Phase III | rekrutiert |
| Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as | Phase III | rekrutiert |
| Phenotypes, Biomarkers and Pathophysiology in Hereditary Spastic Paraplegias and Related Disorde | — | rekrutiert |
| Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients Wi | Phase II | rekrutiert |
| Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - POR | Phase III | rekrutiert |
| Prospective, Randomized Trial of Personalized Medicine With Pentaglobin® After Surgical Infectio | Phase II | rekrutiert |
| Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blin | Phase II | rekrutiert |
| Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer | — | rekrutiert |
| Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study | — | rekrutiert |
| Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Pro | — | rekrutiert |
| Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy | Phase II | rekrutiert |
| Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy - Obser | — | rekrutiert |
| Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Ac | — | rekrutiert |
| Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearran | Phase III | rekrutiert |
| Robotic Curriculum for Young Surgeons | — | rekrutiert |
| Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib | Phase III | rekrutiert |
| Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participan | Phase III | rekrutiert |
| Sporadic Degenerative Ataxia With Adult Onset: Natural History Study | — | rekrutiert |
| Staphylococcus Aureus Network Adaptive Platform Trial | Phase IV | rekrutiert |
| Stroke Thrombectomy and Aneurysm Registry | — | rekrutiert |
| Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or | Phase II | rekrutiert |
| Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With | — | rekrutiert |
| Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe General | Phase III | rekrutiert |
| TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardio | Phase III | rekrutiert |
| The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetini | Phase IV | rekrutiert |
| Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM AL | Phase III | rekrutiert |
| Treatment Recommendations for Gastrointestinal Cancers Via Large Language Models | ohne Phasenangabe | rekrutiert |
| Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established | Phase III | rekrutiert |